 |
|
Expression of Vascular Endothelial Growth Factor in Retinoblastoma
Carolina Areán, MD;
Maria E. Orellana, MD;
Daniel Abourbih, BSc;
Carmen Abreu, BA;
Imelda Pifano, MD;
Miguel N. Burnier Jr, MD, PhD
Arch Ophthalmol. 2010;128(2):223-229. doi:10.1001/archophthalmol.2009.386
Objectives To investigate the immunohistochemical expression of vascular endothelial growth factor (VEGF) and to determine its possible association with tumor differentiation status, optic nerve and/or choroidal invasion, anterior chamber invasion, vitreous seeding, and basophilic staining of the vascular walls.
Methods A retrospective study was performed to identify the expression of VEGF in 47 of 129 consecutive patients with retinoblastoma treated at the Ocular Pathology Laboratory of the Anatomy and Pathology Institute of the Central University of Venezuela in Caracas from January 1, 2000, through December 31, 2007.
Results A positive correlation between VEGF staining intensity and time of progression and mitotic and apoptotic indexes was observed. However, no correlation was found between VEGF expression and other prognostic factors in this malignant neoplasm, including tumor stage as assessed by the Grabowski and Abramson classification.
Conclusions Although the isolated characterization of VEGF in retinoblastoma is not grounds for this protein to be considered a prognostic factor, its association with mitotic and apoptotic indexes suggests it may play a role in the progression of this disease. Thus, therapeutic targeting of VEGF in retinoblastoma may be an effective strategy to reduce tumor progression.
Author Affiliations: Ocular Pathology Section, Dr. José A. O’Daly Anatomy and Pathology Institute, Central University of Venezuela, Caracas (Drs Orellana, Areán, and Pifano and Ms Abreu); and Henry C. Witelson Ocular Pathology Laboratory, McGill University, Montreal, Quebec, Canada (Drs Orellana and Burnier and Mr Abourbih).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
